Status
Acquired by Pfizer on September 1, 2010
Funding Received
$29 Million in 1 Round from 7 Investors
Founded:
2003
Headquarters:
Cambridge, MA
Description:
FoldRx Pharmaceuticals is focused on discovering and developing disease-modifying drug therapies for protein misfolding diseases.
Founders:
Susan L. Lindquist
Categories:
Biotechnology
Website:
http://www.foldrx.com

Detailed Description

Update

FoldRx Pharmaceuticals, Inc. engages in the discovery and development of disease modifying drug therapies for diseases of protein misfolding and amyloidosis. The companyТs pipeline includes a program in advanced clinical development to treat genetic neurologic and cardiovascular disorders, transthyretin-associated amyloidoses with polyneuropathy and TTR-associated amyloidoses with cardiomyopathy, and a discovery program in Parkinson's disease and cystic fibrosis. FoldRx Pharmaceuticals, Inc. was founded in 2003 and is based in Cambridge, Massachusetts.

Current Team (2)

Update

Past Team (3)

Update

Board Members and Advisors (1)

Update

Investors (7)

Update

Offices/Locations (1)

Update
  • Office

    100 Acorn Park Drive

    5th Floor

    Cambridge, MA 02140

    USA